GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (NAS:QDEL) » Definitions » Cyclically Adjusted PS Ratio

QuidelOrtho (QuidelOrtho) Cyclically Adjusted PS Ratio : 1.65 (As of May. 15, 2024)


View and export this data going back to 1992. Start your Free Trial

What is QuidelOrtho Cyclically Adjusted PS Ratio?

As of today (2024-05-15), QuidelOrtho's current share price is $44.18. QuidelOrtho's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $26.77. QuidelOrtho's Cyclically Adjusted PS Ratio for today is 1.65.

The historical rank and industry rank for QuidelOrtho's Cyclically Adjusted PS Ratio or its related term are showing as below:

QDEL' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.57   Med: 6.08   Max: 35.44
Current: 1.57

During the past years, QuidelOrtho's highest Cyclically Adjusted PS Ratio was 35.44. The lowest was 1.57. And the median was 6.08.

QDEL's Cyclically Adjusted PS Ratio is ranked better than
59.58% of 475 companies
in the Medical Devices & Instruments industry
Industry Median: 2.18 vs QDEL: 1.57

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

QuidelOrtho's adjusted revenue per share data for the three months ended in Mar. 2024 was $10.628. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $26.77 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


QuidelOrtho Cyclically Adjusted PS Ratio Historical Data

The historical data trend for QuidelOrtho's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuidelOrtho Cyclically Adjusted PS Ratio Chart

QuidelOrtho Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.26 16.70 9.05 4.01 2.85

QuidelOrtho Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.92 3.47 2.92 2.85 1.79

Competitive Comparison of QuidelOrtho's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, QuidelOrtho's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Cyclically Adjusted PS Ratio falls into.



QuidelOrtho Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

QuidelOrtho's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=44.18/26.77
=1.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuidelOrtho's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, QuidelOrtho's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.628/129.4194*129.4194
=10.628

Current CPI (Mar. 2024) = 129.4194.

QuidelOrtho Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.917 100.560 1.180
201409 1.195 100.428 1.540
201412 1.839 99.070 2.402
201503 1.726 99.621 2.242
201506 1.018 100.684 1.309
201509 1.390 100.392 1.792
201512 1.566 99.792 2.031
201603 1.538 100.470 1.981
201606 1.203 101.688 1.531
201609 1.510 101.861 1.919
201612 1.605 101.863 2.039
201703 2.168 102.862 2.728
201706 1.142 103.349 1.430
201709 1.501 104.136 1.865
201712 3.347 104.011 4.165
201803 4.032 105.290 4.956
201806 2.720 106.317 3.311
201809 2.737 106.507 3.326
201812 3.097 105.998 3.781
201903 3.449 107.251 4.162
201906 2.613 108.070 3.129
201909 2.928 108.329 3.498
201912 3.515 108.420 4.196
202003 4.024 108.902 4.782
202006 4.612 108.767 5.488
202009 10.920 109.815 12.869
202012 18.552 109.897 21.848
202103 8.622 111.754 9.985
202106 4.165 114.631 4.702
202109 11.995 115.734 13.413
202112 14.442 117.630 15.890
202203 23.639 121.301 25.221
202206 11.595 125.017 12.003
202209 11.612 125.227 12.001
202212 12.933 125.222 13.367
202303 12.610 127.348 12.815
202306 9.957 128.729 10.010
202309 11.121 129.860 11.083
202312 11.117 129.419 11.117
202403 10.628 129.419 10.628

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


QuidelOrtho  (NAS:QDEL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


QuidelOrtho Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


QuidelOrtho (QuidelOrtho) Business Description

Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Executives
Louise Brandy officer: SVP, Chief Information Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Patrick Klein officer: Chief Administrative Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Christopher M Smith director 125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Edward L. Michael director 618 SHERIDAN SQUARE, EVANSTON IL 60202
William J. Ferenczy officer: SVP, Cardio/Metabolic Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Werner Kroll officer: SVP, Research and Development 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Kenneth F Buechler director
Robert R. Schmidt director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tamara A. Ranalli officer: SVP, Molecular Bus. Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Stephen H. Wise director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Robert Joseph Bujarski officer: See Remarks C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Wilkins Joseph D Jr. director 82414 PUCCINI DRIVE, INDIO CA 92203
Michelle A. Hodges officer: SVP, General Counsel 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Douglas C Bryant director, officer: Chairman & CEO C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Joseph M Busky officer: Chief Financial Officer 1717 DEERFIELD ROAD, DEERFIELD IL 60015